Evaluating the association between diabetes, cognitive decline and dementia

International Journal of Environmental Research and Public Health

Volumn 12, Issue 7, 2015, Pages 8281-8294

  Ojo, Omorogieva ^a   Brooke, Joanne ^b  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b UNIVERSITY OF WEST LONDON   (United Kingdom)

Author keywords

Alzheimer s disease; Cognitive decline; Dementia; Diabetes; Diabetes complications; Lifestyle interventions; Self management of diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; GLUCOSE BLOOD LEVEL;

COGNITION; DIABETES; HEALTH CARE; HEALTH RISK; LIFESTYLE; MENTAL HEALTH; PUBLIC HEALTH;

ALZHEIMER DISEASE; COGNITIVE DECLINE; COGNITIVE DEFECT; DATA BASE; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; EBSCOHOST RESEARCH DATABASE; EDUCATION PROGRAM; ELECTRONIC DATABASE; EMPOWERMENT; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; LIFESTYLE MODIFICATION; PATHOGENESIS; PATIENT CARE; PATIENT EDUCATION; REVIEW; SELF CARE; SWETSWISE DATABASE; LIFESTYLE; METABOLISM; PATHOPHYSIOLOGY;

BLOOD GLUCOSE; COGNITION DISORDERS; DEMENTIA; DIABETES MELLITUS; HUMANS; LIFE STYLE; SELF CARE;

EID: 84937468538     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph120708281     Document Type: Review

References (43)

1. Ojo, O. Diabetes in ethnic minorities in UK: The role of diet in glucose dysregulation and prevalence of diabetes. J. Food Nutr. Disor. 2013, 2, 1–7.
2. Ojo, O. The impact of changes in health and social care on enteral feeding in the community. Nutrients 2012, 4, 1709–1722.
3. Phillips, S.; Phillips, A. Dementia: A growing problem for older people with diabetes? Pract. Nurs. 2011, 22, 526–531.
4. Strachan, M.W.J.; Reynolds, R.M.; Frier, B.M.; Mitchell, R.J.; Price, J.F. The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies. Diabetes Obes. Metab. 2009, 11, 407–414.
5. Department of Health. Living Well with Dementia: A National Dementia Strategy; The Stationary Office: London, UK, 2009.
6. World Health Organisation. Dementia A Public Health Priority; WHO Press: Geneva, Switzerland, 2012.
7. Alzheimer’s Disease International. The Global Impact of Dementia 2013–2050; Alzheimer’s Disease International: London, UK, 2013.
8. Sanz, C.M.; Hanaire, H.; Vellas, B.J.; Sinclair, A.J.; Andrieu, S.; REAL.FR Study Group. Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer’s disease. The Real.FR Cohort. Diabet. Med. 2012, 29, 541–548.
9. Acee, A.M. Type 2 diabetes and vascular dementia: Assessment and clinical strategies of care. Medsurg Nurs. 2012, 21, 349–384.
10. Carlsson, C.M. Type 2 diabetes mellitus, dyslipidaemia, and Alzheimer’s disease. J. Alzheimers Dis. 2010, 20, 711–722.
11. Parikh, N.M.; Morgan, R.O.; Kunik, M.E.; Chen, H.; Aparasu, R.R.; Yadav, R.K.; Schulz, P.E.; Johnson, M.L. Risk factors for dementia patients over 65 with diabetes. Int. J. Geriatr. Psychiat. 2011, 26, 749–757.
12. Murthy, S.B.; Jawaid, A.; Qureshi, S.U.; Kalkonde, Y.; Wilson, A.M.; Johnson, M.L.; Kunik, M.E.; Schulz, P.E. Does diabetes mellitus alter the onset and clinical course of vascular dementia? Behav. Neurol. 2010, 23, 145–151.
13. Improving Supported Self-management for People with Diabetes. Available online: https://www.diabetes.org.uk/Documents/Reports/Supported_self-management.pdf (accessed on 2 July 2015).
14. Hewitt, J.; Smeeth, L.; Chaturvedi, N.; Bulpitt, C.J.; Fletcher, A.E. Self management and patient understanding of diabetes in the older person. Diabet. Med. 2011, 28, 117–122.
15. Cui, X.; Abduljalil, A.; Manor, B.D.; Peng, C.-K.; Novak, V. Multi-scale glycemic variability: A link to gray matter atrophy and cognitive decline in type 2 diabetes. PLoS ONE 2014, 9, doi:10.1371/journal.pone.0086284.
16. Aung, P.P.; Strachan, M.W.J.; Frier, B.M.; Butcher, I.; Deary, I.J.; Price, J.F.; on behalf of the Edinburgh type 2 diabetes study investigators. Severe hypoglycaemia and late-life cognitive ability in older people with diabetes: The Edinburgh type 2 diabetes study. Diabet. Med. 2012, 29, 328–336.
17. Punthakee, Z.; Miller, M.E.; Launer, L.J.; Williamson, J.D.; Lazar, R.M.; Cukierman-Yaffee, T.; Seaquist, E.R.; Ismail-Beigi, F.; Sullivan, M.D.; Lovato, L.C.; et al. Poor cognitive function and risk of severe hypoglycaemia in type 2 diabetes. Diabetes Care 2012, 35, 787–793.
18. Aveyard, H. Doing a Literature Review in Health and Social Care a Practical Guide, 3rd ed.; Open University Press: Maidenhead, UK, 2014.
19. Ott, A.; Stolk, R.P.; van Harskamp, F.; Pol, H.A.; Hofman, A.; Breteler, M.M. Diabetes mellitus and the risk of dementia: The Rotterdam study. Neurology 1999, 58, 1937–1941.
20. Biessels, G.J.; Staekenborg, S.; Brunner, E.; Brayne, C.; Scheltens, P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol. 2006, 5, 64–74.
21. Stewart, R.; Liolitsa, D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet. Med. 1999, 16, 93–112.
22. Beeri, M.S.; Goldbourt, U.; Silverman, J.M.; Noy, S.; Schmeidler, J.; Ravona-Springer, R.; Davidson, M. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 2004, 63, 1902–1907.
23. Van den Berg, E.; de Craen, A.J.; Biessels, G.J; Gussekloo, J.; Westendorp, R.G. The impact of diabetes mellitus on cognitive decline in the oldest of the old: A prospective population-based study. Diabetologia 2006, 49, 2015–2023.
24. Umegaki, H.; Iimuro, S.; Shinozaki, T.; Araki, A.; Sakurai, T.; Iijima, K.; Ohashi, Y.; Ito, H.; Japanese Elderly Diabetes Intervention trial study group. Risk factors associated with cognitive decline in the elderly with type 2 diabetes. Pooled logistic analysis of a 6-year observation in the Japanese elderly diabetes intervention trial. Geriatr. Gerontol. Int. 2012, 12, 110–116.
25. Gao, L.; Matthews, F.E.; Sargeant, L.A.; Brayne, C.; MRC CFAS. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: From a population based multi-centre longitudinal study. BMC Public Health 2008, 8, doi:10.1186/1471-2458-8-54.
26. Okereke, O.I.; Kang, J.H.; Cook, N.R.; Gaziano, J.M.; Manson, J.E.; Buring, J.E.; Grodstein, F. Type 2 diabetes mellitus and cognitive decline in two large cohorts of community dwelling older adults. J. Amer. Geriatr. Soc. 2008, 56, 1028–1036.
27. Lin, C.H.; Sheu, W.H. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7 year follow up study. J. Intern. Med. 2013, 273, 102–110.
28. Feinkohl, I.; Aung, P.P.; Keller, M.; Robertson, C.M.; Morling, J.R.; McLachlan, S.; Deary, I.J.; Frier, B.M.; Strachan, M.W.; Price, J.F.; et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: The Edinburgh type 2 diabetes study. Diabetes Care 2014, 37, 507–515.
29. Feil, D.G.; Rajan, M.; Soroka, O.; Tseng, C.-L.; Miller, D.R.; Pogach, L.M. Risk of hypoglycaemia in older veterans with dementia and cognitive impairment: Implications for practice and policy. J. Am. Geriatr. Soc. 2011, 59, 2263–2272.
30. Feil, D.G.; Zhu, C.W.; Sultzer, D.L. The relationship between cognitive impairment and diabetes self management in a population based community sample of older adults with type 2 diabetes. J. Behav. Med. 2012, 35, 190–199.
31. Grober, E.; Hall, C.B.; Hahn, S.R.; Lipton, R.B. Memory impairment and executive dysfunction are associated with inadequately controlled diabetes in older adults. J. Prim. Care Community Health 2011, 2, 229–233.
32. Matsuzaki, T.; Sasaki, K.; Tanizaki, Y.; Hata, J.; Fujimi, K.; Matsui, Y.; Sekita, A.; Suzuki, S.O.; Kanba, S.; Kiyohara, Y.; et al. Insulin resistance is associated with the pathology of Alzheimer disease. Neurology 2010, 75, 764–770.
33. Umegaki, H.; Hayashi, T.; Nomura, H.; Yanagawa, M.; Nogogaki, Z.; Nakshima, H.; Kuzuya, M. Cognitive dysfunction: An emerging concept of a new diabetic complication in the elderly. Geriatr. Gerontol. Int. 2013, 13, 28–34.
34. Cholerton, B.; Baker, L.D.; Craft, S. Insulin resistance and pathological brain ageing. Diabet. Med. 2011, 28, 1463–1475.
35. Hammaker, B.G. More than a coincidence: Could Alzheimer’s disease actually be type 3 diabetes? Access 2014, 28, 16–18.
36. Akter, K.; Lanza, E.A.; Martin, S.A.; Myronyuk, N.; Rua, M.; Raffa, R.B. Diabetes mellitus and Alzheimer’s disease: Shared pathology and treatment? Brit. J. Clin. Pharmacol. 2011, 71, 365–376.
37. Kroner, Z. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes? Altern. Med. Rev. 2009, 14, 373–379.
38. De Monte, S.M.; Wands, J.R. Alzheimer’s disease is type 3 diabetes-evidence reviewed. J. Diabetes Sci. Technol. 2008, 2, 1101–1113.
39. Strachan, M.W. The brain as a target organ in type 2 diabetes: Exploring the links with cognitive impairment and dementia. Diabet. Med. 2011, 28, 141–147.
40. Luchsinger, J.A. Type 2 diabetes and related conditions in relation to dementia: An opportunity for prevention? J. Alzheimers Dis. 2010, 20, 723–736.
41. Skinner, T.C.; Carey, M.E.; Cradock, S.; Dallosso, H.M.; Daly, H.; Davies M.J.; Doherty, Y.; Heller, S.; Khunti, K.; Oliver, L.; et al. “Educator talk” and patient change: Some insights from the DESMOND (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed) randomized controlled trial. Diabet. Med. 2008, 25, 1117–1120.
42. Keen, A.J.A.; Duncan, E.; McKillop-Smith, A.; Evans, N.D.; Gold, A.E. Dose adjustment for normal eating (DAFNE) in routine clinical practice: Who benefits? Diabet. Med. 2012, 29, 670–676.
43. Khunti, K.; Gray, L.J.; Skinner, T.; Carey, M.E.; Realf, K.; Dallosso, H.; Fisher, H.; Campbell, M.; Heller, S.; Davies, M.J. Effectiveness of a diabetes education and self-management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: Three year follow-up of a cluster randomised controlled trial in primary care. BMJ 2012, 344, doi:org/10.1136/bmj.e2333.